期刊文献+

具有抗肿瘤活性核苷类似物研究进展 被引量:6

Progress in Researches for Nucleoside Analogues with Anti-tumor Activity
下载PDF
导出
摘要 核苷类似物是一类重要的抗肿瘤药物,对其进行结构改造修饰,提高药物的生物利用度,减少不良反应,已成为核苷类抗肿瘤新药的研究热点。本文通过对药物的化学结构进行分类,分别介绍了碱基修饰、糖基修饰、碱基和糖基同时修饰以及前药修饰的几类核苷类药物及其药理作用机理,阐述了近年来具有抗肿瘤活性的核苷类药物的最新研究进展,为核苷类抗肿瘤药物的研究与开发提供参考。 Nucleoside analogue is an important type of antitumor agents. Structure modification of existing drugs can not only improve the drug bioavailability but also reduce adverse reactions,and it has become a research hotspot of nucleoside anti-tumor agents. In this article,the nucleoside agents were classified according to chemical structure. Several types of drugs,including modification in bases,carbohydrates,both the base and carbohydrates and prodrug modification were reviewed respectively.
出处 《济宁医学院学报》 2016年第1期53-57,共5页 Journal of Jining Medical University
基金 山东省自然科学基金项目(2015 ZRB14337) 山东省高等学校科技计划项目(J15LM13) 济宁医学院大学生创新训练计划项目(CX2015056)
关键词 抗肿瘤 核苷类似物 结构改造 前药设计 研究进展 Anti-tumor Nucleoside analogue Structure modification Prodrug design Progress in research
  • 相关文献

参考文献23

  • 1于红莲.HERV参与肿瘤发生的研究进展[J].济宁医学院学报,2015,38(4):238-242. 被引量:2
  • 2向银洲,余林,魏莲枝.鼻腔鼻窦恶性纤维组织细胞瘤11例临床分析[J].济宁医学院学报,2015,38(5):336-338. 被引量:2
  • 3Mader M M,Henry J R.Antimetabolites,Comprehensive Medicinal Chemistry(11),[M].2007,Volume 7,55-79.
  • 4Magge R S,Deangelis L M.The double-edged sword: Neurotoxicity of chemotherapy[J].Blood Rev,2015,29(2):93-100.DOI:10.1016/j.blre.2014.09.012.
  • 5Van Den Neste E,Van Den Berghe G,Bontemps F.AI- CA-riboside(acadesine),an activator of AMP-activated protein kinase with potential for application in hemato- logic malignancies[J].Expert Opin Investig Drugs,2010,19(4):571-578.DOI:10.1517/13543781003703694.
  • 6Zeidler J,Baraniak D,Ostrowski T.Bioactive nucleoside analogues possessing selected five-membered azahetero- cyclic bases[J].Eur J Med Chem,2015,97(5):409-418.DOI:10.1016/j.ejmech.2014.11.057.
  • 7Musto P,Maurillo L,Spagnoli A A,et al.Azacitidine for the treatment of lower risk myelodysplastic syndromes [J].Cancer,2010,116(6):1485-1494.DOI:10.1002/ cncr.24894.
  • 8Momparler R L,C6t6 S,Momparler L F.Epigenetic ac- tion of decitabine(5-aza-2-deoxycytidine)is more ef- fective against acute myeloid leukemia than cytotoxic ac- tion of cytarabine(ARA-C)[J].Leuk Res,2013,37(8):980-984.DOI:10.1016/j.leukres.2013.04.019.
  • 9Reese N D,Schiller G J.High-dose cytarabine(HD araC)in the treatment of leukemias:a review[J].Curr Hematol Malig Rep,2013,8(2):141-148.DOI:10.1007/sl 1899-013-0156-3.
  • 10Ogura M,Tsukasaki K,Nagai H,et al.Phase I study of BCXl 777(forodesine)in patients with relapsed or re- fractory peripheral T/natural killer-cell malignancies [J].Cancer Sci,2012,103(7):1290-1295.DOI:10.1111/j.1349-7006.2012.02287.

二级参考文献24

  • 1Bivek Karki.Primary malignant fibrous histiocytoma of the abdominal cavity:CT findings and pathological correlation[J].World Journal of Radiology,2012,4(4):151-158. 被引量:15
  • 2Suntsova M, Garazha A, Ivanova A, et al. Molecular functions of human endogenous retroviruses in health and disease[J].Cell Mol Life Sci, 2015 ,Jun 18. [-Epub ahead of print].
  • 3Rycaj K,Plummer J B, Yin B, et al. Cytotoxicity of human endogenous retrovirus K-specific T cells toward autologous ovarian cancer cells[J]. Clin Cancer Res, 2015,21 (2) : 471- 483.
  • 4Li S,Liu Z C,Yin S J,et al. Human endogenous retrovirus W family envelope gene activates the small conductance Ca (2 ~-)-activated K ~ channel in human neuroblastoma cells through CREB[J]. Neuroscience,2013,247: 164-174.
  • 5Nisbet-Brown E, Wegmann TG. Is acquired immunological tolerance genetically transmissible? [J]. Proc Natl Acad Sci U S A,1981,78(9) :5826-5828.
  • 6Yu H L, Zhao Z K , Zhu F. The role of human endogenous retrovirus long terminal repeat in human cancer[J]. Int J Mol Med, 2013,32(4):755-762.
  • 7Cegolon L, Salata C,Weiderpass E, et al. Human endogenous retroviruses and cancer prevention~ evidence and prospects [J]. BMC Cancer, 2013,13 : 4.
  • 8Lokossou A G, Toudic C, Barbeau B. Implication of human endogenous retrovirus envelope proteins in placental func-tions[J].Viruses ,2014,6(11) :4609-4627.
  • 9Holder B S,Tower C L, Abrahams V M, et al. Syncytin 1 in the human placenta[J]. Placenta, 2012,33 (6) : 460-466.
  • 10Medstrand P, Landry J R and Mager DL. Long terminal re- peats are used as alternative promoters for the endothelin B receptor and apolipoprotein C-I genes in humans[J].J Biol Chem,2001,276(3) : 1896-1903.

共引文献2

同被引文献48

引证文献6

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部